Last edited by Gajinn
Tuesday, May 5, 2020 | History

3 edition of Lipoproteins as carriers of pharmacological agents found in the catalog.

Lipoproteins as carriers of pharmacological agents

  • 379 Want to read
  • 5 Currently reading

Published by Dekker in New York .
Written in English

    Subjects:
  • Lipoprotein drug carriers.,
  • Drug Carriers.,
  • Lipoproteins -- administration & dosage.

  • Edition Notes

    Includes bibliographical references and index.

    Statementedited by J. Michael Shaw.
    SeriesTargeted diagnosis and therapy ;, 5
    ContributionsShaw, J. Michael, 1944-
    Classifications
    LC ClassificationsRS201.L53 L56 1991
    The Physical Object
    Paginationxi, 404 p. :
    Number of Pages404
    ID Numbers
    Open LibraryOL1538101M
    ISBN 100824785053
    LC Control Number91016479

    A drug carrier is any substrate used in the process of drug delivery which serves to improve the selectivity, effectiveness, and/or safety of drug administration. Drug carriers are primarily used to control the release of a drug into systemic circulation. This can be accomplished either by slow release of the drug over a long period of time (typically diffusion) or by triggered release at the. Abstract. Lipoproteins are blood-soluble, complex aggregates of proteins and lipids. They are the major carriers of cholesterol, cholesterol esters, phospholipids, triglycerides, and other lipids such as fat-soluble vitamins*.

    The main lipid carriers in the insect circulatory system are the lipoproteins lipophorin and vitellogenin. In some species, the endocytosis of lipophorin and vitellogenin may account for about 10%.   Cholesterol, Lipoproteins & Lipids: Understanding CVD Risk (Sigma Statement) In Sigma Statements by Alan Flanagan Janu Leave a Comment This is the first published 'Sigma Statement', which represents what we feel to be the best current interpretation of the evidence related to an important, confusing and/or controversial topic in.

    Lipoprotein(a) is a lipoprotein particle of a certain phenotype High-density lipoproteins (HDL) collect fat molecules from the body's cells/tissues and take them back to the liver. HDLs are sometimes referred to as "good" lipoprotein because higher concentrations correlate with low rates of atherosclerosis progression and/or regression. Rhabdomyolysis One adverse effect with potentially serious consequences is muscle damage, the exact cause of which is not known. The most serious skeletal muscle effect that may result from lovastatin is rhabdomyolysis, although it is very rare (occurring in % of patients on statins as monotherapy).


Share this book
You might also like
Midwinter

Midwinter

Food trade news whos who in the greater Philadelphia food industry

Food trade news whos who in the greater Philadelphia food industry

childs first book of Bible stories

childs first book of Bible stories

Encyclopedia of World Geography

Encyclopedia of World Geography

Medical care for self-employed fishermen.

Medical care for self-employed fishermen.

The 19th Century and Abolition (Voices in African American History Series)

The 19th Century and Abolition (Voices in African American History Series)

Raffle for a wife

Raffle for a wife

Current estimates from the National Health Interview Survey, United States, 1982.

Current estimates from the National Health Interview Survey, United States, 1982.

Secret wars

Secret wars

Silent speech, a language

Silent speech, a language

More than two

More than two

Epping Forest District

Epping Forest District

Discussion paper : Task Force on the Future of the Canadian Financial Services Sector =

Discussion paper : Task Force on the Future of the Canadian Financial Services Sector =

Matti Khavab aur Khun

Matti Khavab aur Khun

Government and business in India

Government and business in India

Lipoproteins as carriers of pharmacological agents Download PDF EPUB FB2

Lipoproteins as Carriers of Pharmacological Agents (TARGETED DIAGNOSIS AND THERAPY): Medicine & Health Science Books @ Skip to main content Try PrimeFormat: Hardcover. Lipoproteins as Carriers of Pharmacological Agents (TARGETED DIAGNOSIS AND THERAPY Book 5) - Kindle edition by Shaw, Michael.

Download it once and read it on your Kindle device, PC, phones or cturer: Routledge. Explores endogenous lipoprotein particles and their interaction with pharmacological agents. Among the topics are receptor-dependent interactions of lipoproteins with tissues and cell types, their uptake and transport with the vascular endothelium, therapeutic and chemical agents Cited by: This chapter summarizes the in vivo potency of lipoproteins as carriers of pharmacological agents and as possible vehicles in drug delivery.

It discusses the problems concerned with the in vivo application of lipoproteins in drug delivery. Explores endogenous lipoprotein particles and their interaction with pharmacological agents. This title covers topics such as receptor-dependent interactions of lipoproteins with tissues and cell types, and their uptake and transport with the vascular endothelium.

Lipoproteins As Carriers Of Pharmacological Agents (Targeted Diagnosis And Therapy) - Hardcover quantity Add to cart SKU: Categories: Drug Delivery Systems, Hardcover, Medical Pharmacology Tags:, CRC Press, English, Hardcover, NULL.

Get this from a library. Lipoproteins as Carriers of Pharmacological Agents. [Michael Shaw] -- "Explores endogenous lipoprotein particles and their interaction with pharmacological agents. Among the topics are receptor-dependent interactions of lipoproteins with tissues and cell types, their.

Buy the Hardcover Book Lipoproteins As Carriers Of Pharmacological Agents by Michael Shaw atCanada's largest bookstore. Free shipping and pickup in store on eligible orders.

University of Kansas Medical Center Rainbow Boulevard Kansas City, KS | TDD. The ability of plasma lipoproteins to act as carriers in sitespecific drug delivery systems was evaluated by determining the disposition and pharmacological effects of β‐sitosteryl‐β‐ D ‐glucopyranoside (SG, 3).In the disposition studies, [3 H]SG was absorbed from the intestinal tract by the formation of chylomicrons and was specifically associated with lipoproteins in by: Find many great new & used options and get the best deals for Lipoproteins As Carriers of Pharmacological Agents Vol.

5 (, Hardcover) at the best online prices at. Lipoproteins as. Pharmaceutical Carriers Lipoproteins as Pharmaceutical Carriers Lipoproteins are such structures which function as natural biological carriers and transport various types of lipids in blood circulation Lipoproteins - efficient carriers for anticancer drugs, gene or other type of compounds.

ApoBcontaining Lipoproteins Are Major Carriers of 3-Iodothyronamine in Circulation Article in Journal of Biological Chemistry (3) November with 25.

Cholesterol, triglycerides, and high-density lipoproteins are important constituents of the lipid fraction of the human body.

Cholesterol is an unsaturated alcohol of the steroid family of compounds; it is essential for the normal function of all animal cells and is a fundamental element of their cell membranes. It is also a precursor of various critical substances such as adrenal and gonadal Cited by: Keywords:Synthetic lipoproteins, nanocarriers, drug delivery, advantages, development, applications.

Abstract:Synthetic lipoprotein is an effective carrier of targeted delivery for drugs. It has the very small size, good biocompatibility, suitable half-life, and specific lipoprotein receptorbinding by: 1.

Lipoproteins as Carriers of Pharmacological Agents (TARGETED DIAGNOSIS AND THERAPY Book 5) price $ 54 Liposomes in Drug Delivery (Drug Targeting and Delivery Book 2).

Lipoproteins are biological lipid carriers play important role in transport of fats within the body. 1 These are natural nanoparticles which serve as drug-delivery vehicles due to their small size, long residence time in the circulation. 2 Low-density lipoprotein (LDL) carries cholesterol in plasma 3 and play important role in its metabolism in normal cells as well as in cancer cells.

Key issues in the delivery of pharmacological agents using lipoproteins: design of a synthetic apoprotein–lipid carrier. Target. Diagn. Ther. 5,– ().Medline, CAS, Google Scholar; 50 de Smidt PC, Versluis AJ, van Berkel TJ.

Properties of incorporation, redistribution, and integrity of porphyrin-low-density lipoprotein by: Monographs, 4) Lipoproteins as Carriers of Pharmacological Agents (Targeted Diagnosis and Therapy) Infants and Children: Prenatal through Middle Childhood (8th Edition) (Berk & Meyers, The Infants, Children, and Adolescents Series, 8th Edition) Orthomolecular Medicine for Everyone.

Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.

Molec. Pharmacol. 52, ().Cited by:. The emulsification of dietary fats renders them accessible to various pancreatic lipases in the small intestine.

These lipases, pancreatic lipase and pancreatic phospholipase A 2 (PLA 2) generate free fatty acids and a mixture of mono- and diglycerides from dietary atic lipase degrades triglyceride at the sn-1 and sn-3 positions sequentially to generate 1,2-diglycerides and.Monographs, 4) Lipoproteins as Carriers of Pharmacological Agents (Targeted Diagnosis and Therapy) Orthomolecular Medicine for Everyone: Megavitamin Therapeutics for Families and Physicians Religious Therapeutics: Body and Health in Yoga, Ayurveda, and Tantra (SUNY Series.The Molecular Nutrition of Fats presents the nutritional and molecular aspects of fats by assessing their dietary components, their structural and metabolic effects on the cell, and their role in health and disease.

Subject areas include molecular mechanisms, membranes, polymorphisms, SNPs, genomic wide analysis, genotypes, gene expression.